Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Nonparametric Estimation from Incomplete Observations

1958 • 7,673 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Cancer incidence, mortality and prevalence worldwide

2004 • 3,893 citations

Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

2003 • 3,010 citations

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

2000 • 2,411 citations

Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma

1999 • 1,063 citations

Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma

2003 • 868 citations

On distribution-free tests for equality of survival distributions

1977 • 709 citations

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin

1985 • 392 citations

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck

1998 • 203 citations

Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?

1997 • 98 citations

Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy

1991 • 83 citations

Induction chemotherapy with paclitaxel, cisplatin and5-fluorouracil for squamous cell carcinoma of the head and neck: long-term results of a phase II trial

2002 • 67 citations

A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies.

1995 • 66 citations

Analysis of Complete Responders after Initial Treatment with Chemotherapy in Head and Neck Cancer

1985 • 46 citations

Methodologic considerations in the design and conduct of randomized trials: the U.S. Physicians' Health Study

1989 • 40 citations

Designing clinical trials for two-sided multiple comparisons with a control

1989 • 34 citations

Two-sample Kolmogorov-Smirnov test for truncated data

1977 • 10 citations

Kappa as an index of reproducibility: distribution under the null-hypothesis.

1987 • 6 citations